Author details

Full Name

Alistair S Hall

Affiliation

ORCID

Career Start Year

1989

Papers

241

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
34533690	The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases.	Cardiovascular Drugs and Therapy	2023
37400679	ACE inhibitors and the risk of lung cancer-is there causality?		2023
37451698	Cohort profile: Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) Longitudinal Cohort.		2023
36737125	ACEI and ARB - Each Unique RAAS Inhibitors: The Importance of Impact on Inflammation.		2023
35363781	Heteroplasmic mitochondrial DNA variants in cardiovascular diseases.	PLoS Genet	2022
35393352	Innovative, centralised, multidisciplinary medicines optimisation clinic for PCSK9 inhibitors.	Open Heart	2022
36351712	Sex differences in health-related quality of life trajectories following myocardial infarction: national longitudinal cohort study.	BMJ Open	2022
34579718	Association of multimorbidity and changes in health-related quality of life following myocardial infarction: a UK multicentre longitudinal patient-reported outcomes study.	BMC Medicine	2021
33452123	Long-term survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure.	Heart	2021
32738919	Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process.	Trials	2020
31699696	Quality of life trajectories in survivors of acute myocardial infarction: a national longitudinal study.	Heart	2020
32013880	The my experience of taking medicines (MYMEDS) questionnaire for assessing medicines adherence barriers in post-myocardial infarction patients: development and utility.	BMC Cardiovascular Disorders	2020
33154065	Ensuring that COVID-19 research is inclusive: guidance from the NIHR INCLUDE project.	BMJ Open	2020
32826289	Association of cardiac rehabilitation and health-related quality of life following acute myocardial infarction.	Heart	2020
32530790	Wellness for Allied Healthcare Professionals in the Age of COVID-19.	Neurodiagnostic journal,The	2020
31354954	Adherence to coronary artery disease secondary prevention medicines: exploring modifiable barriers.	Open Heart	2019
29277343	The Divergent Cardiovascular Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockers in Adult Patients With Type 2 Diabetes Mellitus.		2018
30144828	Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: protocol for a systematic review and meta-regression analysis.	Systematic Reviews	2018
30613417	Re-engineering the post-myocardial infarction medicines optimisation pathway: a retrospective analysis of a joint consultant pharmacist and cardiologist clinic model.	Open Heart	2018
29572276	Reaching the wrong conclusion: residual confounding by indication.	Heart	2018
28209224	Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated WithÂ Coronary ArteryÂ Disease.	J Am Coll Cardiol	2017
28506971	Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease.	Circ Res	2017
28461624	Loss of Cardioprotective Effects at the ADAMTS7 Locus as a Result of Gene-Smoking Interactions.	Circulation	2017
28797268	Do expanded seven-day NHS services improve clinical outcomes? Analysis of comparative institutional performance from the "NHS Services, Seven Days a Week" project 2013-2016.	BMC Health Serv Res	2017
28559493	Angiotensin Receptor Blockers Do Not Reduce Risk of Myocardial Infarction, Cardiovascular Death, or Total Mortality: Further Evidence for the ARB-MI Paradox.	Circulation	2017
28267856	Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease.	JAMA	2017
27731410	No Association of Coronary Artery Disease with X-Chromosomal Variants in Comprehensive International Meta-Analysis.	Sci Rep	2016
26934567	Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.	N Engl J Med	2016
27192541	Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease.	N Engl J Med	2016
26857212	Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification.	Heart	2016
26512829	An evaluation of 20 year survival in patients with diabetes mellitus and acute myocardial infarction.	International Journal of Cardiology	2016
26586276	The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and Death.	Progress in Cardiovascular Diseases	2016
28007139	Phenotypic Characterization of GeneticallyÂ Lowered Human Lipoprotein(a) Levels.	J Am Coll Cardiol	2016
27653574	Blood-Pressure and Cholesterol Lowering in the HOPE-3 Trial.	New England Journal of Medicine	2016
25079365	The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study.	European Heart Journal	2015
25673413	Genetic studies of body mass index yield new insights for obesity biology.	Nature	2015
25712996	Age- and sex-specific causal effects of adiposity on cardiovascular risk factors.	Diabetes	2015
25658981	Analysis of gene-gene interactions among common variants in candidate cardiovascular genes in coronary artery disease.	PLoS ONE	2015
25853659	Genetically determined height and coronary artery disease.	N Engl J Med	2015
25948422	Expedited discharge with high-sensitivity (hs) troponin.	Heart	2015
27066539	Genetic analysis for a shared biological basis between migraine and coronary artery disease.	Neurol Genet	2015
26016847	Adiposity as a cause of cardiovascular disease: a Mendelian randomization study.	Int J Epidemiol	2015
26343387	A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.	Nat Genet	2015
26114160	Cumulative effects of common genetic variants on risk of sudden cardiac death.	Int J Cardiol Heart Vasc	2015
26105029	Evaluation of the Methods and Management of Acute Coronary Events (EMMACE)-3: protocol for a longitudinal study.	BMJ Open	2015
24474739	Mendelian randomization of blood lipids for coronary heart disease.	Eur Heart J	2015
25228048	Mortality and missed opportunities along the pathway of care for ST-elevation myocardial infarction: a national cohort study.	European Heart Journal: Acute Cardiovascular Care	2015
24698468	Effects of angiotensin-converting enzyme inhibitors and beta blockers on clinical outcomes in patients with and without coronary artery obstructions at angiography (from a Register-Based Cohort Study on Acute Coronary Syndromes).	American Journal of Cardiology	2014
25282103	Defining the role of common variation in the genomic and biological architecture of adult human height.	Nat Genet	2014
24453098	Impact of aspirin and statins on long-term survival in patients hospitalized with acute myocardial infarction complicated by heart failure: an analysis of 1706 patients.	Eur J Heart Fail	2014